Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis
Explore this paper's citation graph
Summary
The incidence, clinical manifestations, and natural history of cyclophosphamide-mediated urotoxicity in a cohort of patients with Wegener granulomatosis are described and recommendations for surveillance are discussed.
- Type
- article
- Published
- 1996-03-01
- Cited by
- 554
- References
- 24
- OpenAlex
- https://openalex.org/W1984702041
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:25764336
Keywords
Medicine, Cyclophosphamide, Hemorrhagic cystitis, Cystoscopy, Bladder cancer
References
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study.
- Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.
- Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.
- Covariance Analysis of Heart Transplant Survival Data
- Wegener Granulomatosis: An Analysis of 158 Patients
- Cyclophosphamide cystitis--identification of acrolein as the causative agent.
- Cyclophosphamide toxicity. Characterising and avoiding the problem.
- Cytological study of the effect of cyclophosphamide on the epithelium of the urinary bladder in man
- WEGENER'S GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATURE
- Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.
- An improved Bonferroni procedure for multiple tests of significance
- Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years.
- Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres.
- An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.
- Carcinoma of the urinary bladder after treatment with cyclophosphamide for non-Hodgkin's lymphoma.
- The cytodiagnosis of human polyomavirus infection.
- Wegener's granulomatosis. Long-term followup of patients treated with cyclophosphamide.
- [Ulcerative colitis].
- Nonparametric Estimation from Incomplete Observations
- Regression Models and Life-Tables
Cited by
- Uso de fármacos modificadores de la enfermedad en artritis reumatoide
- Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features.
- Combination therapy in autoimmune disease: vasculitis
- Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis
- Lymphocyte counts in patients with ANCA-associated vasculitis
- Cancer preceding Wegener's granulomatosis: a case-control study.
- Risque de cancer chez les dialysés et transplantés rénaux
- Incidence of sterile hemorrhagic cystitis in tumor-bearing dogs concurrently treated with oral metronomic cyclophosphamide chemotherapy and furosemide: 55 cases (2009-2015).
- Entwicklung von Morbidität und Mortalität bei ANCA-assoziierten Vaskulitiden
- Immunosuppressive treatments in multiple sclerosis.
- Presenting features in Pakistani patients suffering from the antineutrophil cytoplasmic antibody--classical subtype (c-ANCA) associated vasculitis.
- Disease-specific quality indicators, guidelines, and outcome measures in vasculitis.
- Granulomatosis de Wegener: Un nuevo caso clínico de inicio nasal
- Are chronic dialysis patients at increased risk for cancer?
- Vasculitis and stroke.
- Cancer incidence in pulmonary vasculitis.
- Discontinuation of therapies in vasculitis.
- 大顆粒リンパ球白血病 (large granular lymphocyte leukemia) 合併赤芽球癆の病態と治療
- Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment.
- Interferon-alpha for maintenance of remission in Churg-Strauss syndrome: a long-term observational study.
Related papers
- Evaluation of effects of chitosan in preventing hemorrhagic cystitis in rats induced by cyclophosphamide.
- Comparison of the uroprotective efficacy of mesna and HBO treatments in cyclophosphamide-induced hemorrhagic cystitis.
- Low‐Dose Cyclophosphamide Associated with Hemorrhagic Cystitis in a Breast Cancer Patient
- Intravesical instillation of dilute formalin for treatment of cyclophosphamide-induced hemorrhagic cystitis in two dogs.
- Efficacy of mesna in preventing further cyclophosphamide-induced hemorrhagic cystitis.
- Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis.
- Outcome of Canine Multicentric Lymphoma after Single or Divided Treatment with Cyclophosphamide in Multidrug Chemotherapy.
- Cyclophosphamide--hemorrhagic cystitis following prolonged low-dose therapy.
- Managing a side effect: Cyclophosphamide-induced hemorrhagic cystitis
- Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs.